**Nutrien (NTR) shares rose 7.9% to $66.20 on heightened trading volume, recovering from a 0.8% decline over the past four weeks. This surge followed an upgrade by Morgan Stanley, which increased its rating from “Equal-Weight” to “Overweight” and raised the price target from $70 to $77.**
**Expected earnings for the upcoming quarterly report are $0.87 per share, marking a substantial year-over-year increase of 180.7%, with revenues projected at $5.24 billion, a 3.2% rise compared to the previous year.**
**Nutrien currently holds a Zacks Rank of #3 (Hold), while competitor CF Industries (CF) closed at $85.05, up 2.6% with an unchanged EPS estimate for the quarter at $2.55, reflecting a 34.9% increase year-over-year.**
